A PACS Admin’s Life

One man takes on the world of PACS, RIS, dicom, and all that is digital imaging.
Sep 24th 2008
Tags: pacs

Related Posts:
  • Lantheus joins Bracco for promotion of CardioGen-82
    • ...

  • Block Imaging, Dicom Solutions to offer new products
    • ...

  • PACS Used To Streamline/Increase Volumes
    • ...

  • Intelerad, peerVue Sign Partnership Agreement | News | Imaging Economics
    • ...

    FDA warns Covidien about adulterated imaging agent at Missouri plant

    The FDA has sent a warning letter to Covidien’s CEO and President
    Richard J. Meelia, based on an inspection of its pharmaceutical
    manufacturing operation Maryland Heights, Mo., that “revealed serious
    deviations from the good manufacturing practice regulations.”

    Bookmark to:
    Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to Del.icio.us Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to digg Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to FURL Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to blinklist Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to My-Tuts Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to reddit Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to Feed Me Links! Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to Technorati Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to Socializer 

    Syndicate

    Sponsership Centre

    Activity

    No comments, leave your comment or trackback.

    Leave a Reply


    Search

    The archives run deep. Feel free to search older content using topic keywords.

      You're new! If you like it here, please subscribe to my feed.      
    [Close]